Pancreatic Cancer Cures And Surviving Pancreatic Cancer

Pancreatic Cancer Cures are what frees the individual from pancreatic cancer. It is not considered a cure until the individual has lived five years after diagnosis. There are many mistaken beliefs about pancreatic cancer as to how long people are surviving pancreatic cancer and what life expectancy they will have. Firstly, it is thought to be a terminal illness and that a rapid death is pending. This may be true for a number of people but it is imperative to acknowledge that the most people identified with pancreatic cancer can be helped. Usually substantially, in both how long, they will live and how well they will experience their life.

It is imperative to keep in mind that any pancreatic cancer mortality numbers for five years mortality only judge's individuals who had a diagnosis made over five years ago. In view of that fact, there has been considerable progress in all areas of pancreatic cancer treatments; pancreatic cancer prognosis is probably very much higher than what it was five years ago.

Pancreatic cancer cures can take place in clinical trials. These are research studies by experts in the field of oncology to test new treatment on human subjects. Oncology studies cancer. It is concerned with five major areas. These are etiology, biology, diagnosis, treatment and prevention. Oncology has led to most valuable advance in the understanding of pancreatic cancer, treatments and cures. Oncologists are medical doctors who devote themselves to the treatment of cancer and further proficiency as radiation therapy, surgical or medical oncologists.

Pancreatic cancer cures can take the form of a pancreatic cancer vaccine. Vaccines may be used at all pancreatic cancer stages One type of vaccine is used in adjuvant therapy (after pancreatic cancer surgery), to reduce the chances of the cancer returning. Prior to these vaccines being made available, adjuvant therapy involved a combination of chemotherapy and radiation treatment.

Another possibility for pancreatic cancer cures using the vaccine approach, in patients who have undergone pancreatic cancer surgery to completely remove the tumor. They are then given pancreatic cancer treatment in the form of a vaccine to immunize and protect the person against an abnormal gene. This is a gene that is exclusive to pancreatic cancer cells. Initially results point towards this immunization approach being very safe and well tolerated and an aid towards surviving pancreatic cancer for longer.

Pancreatic cancer cures in clinical trials have progressed with an immune boosting vaccine. Early indications show better odds of surviving pancreatic cancer. With this vaccination, the average results have increase from sixty three percent to eight percent one year after diagnosis. Averages of pancreatic cancer patients treated with the vaccine alive two years after diagnosis went from forty two percent to seventy six percent. This is still not reaching the five-year marker necessary to be classed as a complete cure but progress is constantly being made and so much is dependent upon the stage of the pancreatic cancer and the person's ability to function in daily life.

Pancreatic cancer clinical trials are using this vaccine collectively with conventional surgery and postoperative radiation treatment and chemotherapy. The vaccine emits a molecule that attracts the body's immune cells to the location of the cancer. Once attracted to the tumor, the immune cells lifts up other antigens from the exterior of the irradiated cells. This helps to recognize and wipe out any residual active cancer cells in the persons body.

It is therefore possible to see that much progress is being made with these and other pancreatic cures, although at the moment, the best chance of surviving pancreatic cancer is dependent on an early diagnosis.